Vemurafenib improves overall survival compared to dacarbazine in advanced BRAFV600E mutated melanoma: an update from the phase III randomized, open-label, multicenter BRIM3 trial
Year: 2011
Type: article
Authors: Axel Hauschild, McArthur Ga, Caroline Robert, Haanen Jb, Paolo A. Ascierto, James Larkin, Reinhard Dummer, Claus Garbe, Alberto Testori, Maio Michele, David Hogg, Paul Lorigan, Célèste Lebbé, Thomas Jouary, Dirk Schadendorf, A. Ribas, S. O’Day, Sosman Ja, John M. Kirkwood, A Eggermont, Brigitte Dréno, K. B. Nolop, Li J, Betty J Nelson, Joe A, Lee Rj, KT Flaherty, PB Chapman
Language: English
Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W1523356779